Identifikatoren & physikalische Daten
| Summenformel | C3H5O3- |
|---|
| Durchschnittliche Molmasse | 89,07 g/mol |
|---|
| Monoisotopische Masse | 89,02386902 g/mol |
|---|
| SMILES | O=C([O-])CCO |
|---|
| InChIKey | ALRHLSYJTWAHJZ-UHFFFAOYSA-M |
|---|
| PubChem CID | 5459847 |
|---|
| ChEBI | CHEBI:16510 |
|---|
Chemische & physikalische Eigenschaften
| XLogP | -0,3 |
|---|
| Polarare Oberfläche (TPSA) | 60,4 |
|---|
| H-Brücken-Donoren | 1 |
|---|
| H-Brücken-Akzeptoren | 3 |
|---|
| Frei drehbare Bindungen | 1 |
|---|
| Schwere Atome | 6 |
|---|
| Formalladung | -1 |
|---|
| Komplexität | 44 |
|---|
Sicherheit & Vorschriften
| Gesundheitliche Auswirkungen | Chronically high levels of hydroxypropionic acid are associated with at least 5 inborn errors of metabolism including: Biotinidase deficiency, Malonic Aciduria, Methylmalonate Semialdehyde Dehydrogenase Deficiency, Methylmalonic Aciduria, Methylmalonic, Aciduria Due to Cobalamin-Related Disorders and Propionic acidemia. |
|---|
| Toxizitätsübersicht | 3-hydroxypropionic acid (3HP) toxicity is mediated by 3-hydroxypropionic aldehyde (reuterin). 3HP toxicity is also proposed to be related to inhibition of the chorismate and threonine super-pathways. Generally, the toxicity mechanism of 3HP is not understood at the molecular level. (A15450) |
|---|
| Carcinogen Classification | No indication of carcinogenicity to humans (not listed by IARC). |
|---|
